United States · FDA National Drug Code directory

Dexlansoprazole delayed release

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
72162-2239_7be7b733-4992-4eb4-9cb3-d240a878d371
Product NDC
72162-2239
Form
CAPSULE, DELAYED RELEASE
Composition / generic term
dexlansoprazole
Labeler
Bryant Ranch Prepack
Marketing category
ANDA
Marketing start / end (source format)
20221201
Source listing expiry
20271231

Source-listed ingredients

  • DEXLANSOPRAZOLE — 60 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (72162-2239-3) · 72162-2239-3
  • 90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (72162-2239-9) · 72162-2239-9

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →